TP53 and neoplasm: The complete absence then of TP53 mutation in any of the 72 tumours (from 34 children with a predisposing WT1 event) provide a genetic explanation for the exceptional rarity of TP53-associated high risk histology (i.e. diffuse anaplasia) in primary tumours of children with germline WT1 mutations.